Related: China cracks down on fake data in drug trials – Nature (free) AND China launches crackdown on academic fraud – Financial Times (a few articles per month are free)
Insurers Battle Families Over Costly Drug for Fatal Disease – The New York Times (10 articles per month are free)
“Verbal and physical attacks against health care workers are common, are underreported, and have lasting consequences in the form of persistent fear”.
“Financial conflicts of interest are commonplace in clinical practice guidelines”
See more on direct-to-consumer genetic testing in our May 29th issue, see #3.
The tyranny of excessive medical hierarchy – MJA Insight (free) (RT @pash22 see Tweet)
Why are doctors killing themselves? – by Anne Malatt, via MJA Insight (free)
See more on Standardized Criteria for Palliative Care Consultation in our April 24 issue, see #8
“I have to fly tonight because they are shooting my donor tomorrow.”
Viewpoint: Direct-to-Consumer Medical Testing in the Era of Value-Based Care – JAMA (free)
Editor’s Choice: Give patients access to their medical records – The BMJ, by Fiona Godlee, editor in chief (free)
Patients are being empowered in decisions regarding their health care, and this is probably a tendency for the future.
Transplantation of HCV-infected-kidneys into uninfected recipients seems feasible in this era of direct-acting antiviral agents, maybe shortening waiting times for those willing to take the risk.
Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing4 May, 2017 | 20:14h | UTC
Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing – JAMA (link to abstract – $ for full-text)
Commentaries: Doctors Prescribe More Generics When Drug Reps Are Kept At Bay – NPR (free) AND Limiting Interactions with Pharma Reps Cuts Brand Name Drug Prescriptions – Physician’s First Watch (free)
“Historically, the practice has been “if in doubt, err on the side of aggressive, life-sustaining treatment,””. That might be changing.
F.D.A. Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers – The New York Times (10 articles per month are free)
See also: Before you send your spit to 23andMe, what you need to know – STAT News (free) AND 23andMe given green light to sell DNA tests for 10 diseases – Nature News (free) AND 23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease Risk – Forbes (free) AND Too Much Information? FDA Clears 23AndMe to Sell Home Genetic Tests for Alzheimer’s and Parkinson’s – Scientific American (free)
“The controversial step will significantly expand direct-to-consumer testing – but what if the news is bad?” (from Scientific American above)
*Very interesting, but do we want to know?*